CHICAGO — In the RIVAWAR trial, patients hospitalized for a heart attack who were treated with rivaroxaban for left ventricular thrombus had comparable outcomes at 3 months to patients treated ...
The FDA approved fitusiran (Qfitlia, Sanofi) for routine prophylaxis for prevention or reduction in bleeding episodes in ...
5don MSN
Damian Lillard has no timeline to return to the Milwaukee Bucks after being diagnosed with deep vein thrombosis in his right ...
March is Blood Clot Awareness Month, and health officials are raising concerns about the risks associated with venous ...
A study shows reduced-dose apixaban effectively prevents recurrent blood clots in cancer patients, lowering bleeding risks ...
News Medical on MSN4d
Machine learning program enhances transplant risk assessment in myelofibrosis patients better than current modelsA machine learning model generated by a team from the European Society for Blood and Marrow Transplantation (EBMT) outperformed standard statistical models in identifying and stratifying transplant ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback